New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting
Elisabeth Heßmann(Universitätsmedizin Göttingen), Andreas Trumpp(German Cancer Research Center), Jennifer P. Morton(Cancer Research UK), Susanne Sebens(Hochschule für Angewandte Wissenschaften Kiel), Stephan B. Dreyer, Shiv K. Singh(Universitätsmedizin Göttingen), Patrick Michl(Heidelberg University), Bastian Krenz(University of Würzburg), Martin Eilers(University of Würzburg), Elisa Espinet(Institut d'Investigació Biomédica de Bellvitge), Alexander Kleger(Universität Ulm), Feda H. Hamdan, Steven A. Johnsen(Universitätsmedizin Göttingen), Gwen Lomberk(Medical College of Wisconsin), Channing J. Der(University of North Carolina at Chapel Hill), Anneli Gebhardt, Marina Pasca di Magliano(OncoMed (United States)), Felix S.R. Picard, Jens T. Siveke(German Cancer Research Center), Maximilian Reichert(TUM Klinikum), Chiara Falcomatà(Icahn School of Medicine at Mount Sinai), Corinne Bousquet(Centre National de la Recherche Scientifique), Thomas M. Gress(Universitätsklinikum Gießen und Marburg), Günter Schneider(TUM Klinikum), Paweł K. Mazur(The University of Texas MD Anderson Cancer Center), Dieter Saur(German Cancer Research Center), Roland M. Schmid(Tumkur University), Karin Feldmann, Nelson Dusetti(Centre National de la Recherche Scientifique), Volker Ellenrieder(Universitätsmedizin Göttingen), Magdalena Huber(Philipps University of Marburg)
Cited by 5
Related Papers
Myc’s broad reach
|Genes & Development|2008|922
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
|Journal of Clinical Investigation|1998|737
Rho-family GTPases: it's not only Rac and Rho (and I like it)
|Journal of Cell Science|2004|594